The Conversation (0)
VANC Pharmaceuticals Obtains NPNs For 4 Products
Nov. 19, 2014 10:43AM PST
Life Science Investing NewsVANC Pharmaceuticals Inc. (TSXV:NPH,OTCQB:NUVPF) has obtained Natural Product Number approvals for: FerroHEME (heme-iron supplement), PEDIA-SAFE drops (multivitamin dietary supplement for infant and children), SennaLax (natural laxative) and T36 Ointment (disinfectant and corticosteroid).
VANC Pharmaceuticals Inc. (TSXV:NPH,OTCQB:NUVPF) has obtained Natural Product Number approvals for: FerroHEME (heme-iron supplement), PEDIA-SAFE drops (multivitamin dietary supplement for infant and children), SennaLax (natural laxative) and T36 Ointment (disinfectant and corticosteroid).
As quoted in the press release:
Vanc plans to manufacture these products and start sales and marketing activities for them beginning in Q1-2015.
Click here to read the VANC Pharmaceuticals Inc. (TSXV:NPH,OTCQB:NUVPF) press release